Literature DB >> 10880396

Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.

B Kornek1, M K Storch, R Weissert, E Wallstroem, A Stefferl, T Olsson, C Linington, M Schmidbauer, H Lassmann.   

Abstract

Recent magnetic resonance (MR) studies of multiple sclerosis lesions indicate that axonal injury is a major correlate of permanent clinical deficit. In the present study we systematically quantified acute axonal injury, defined by immunoreactivity for beta-amyloid-precursor-protein in dystrophic neurites, in the central nervous system of 22 multiple sclerosis patients and 18 rats with myelin-oligodendrocyte glycoprotein (MOG)-induced chronic autoimmune encephalomyelitis (EAE). The highest incidence of acute axonal injury was found during active demyelination, which was associated with axonal damage in periplaque and in the normal appearing white matter of actively demyelinating cases. In addition, low but significant axonal injury was also observed in inactive demyelinated plaques. In contrast, no significant axonal damage was found in remyelinated shadow plaques. The patterns of axonal pathology in chronic active EAE were qualitatively and quantitatively similar to those found in multiple sclerosis. Our studies confirm previous observations of axonal destruction in multiple sclerosis lesions during active demyelination, but also indicate that ongoing axonal damage in inactive lesions may significantly contribute to the clinical progression of the disease. The results further emphasize that MOG-induced EAE may serve as a suitable model for testing axon-protective therapies in inflammatory demyelinating conditions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10880396      PMCID: PMC1850217          DOI: 10.1016/S0002-9440(10)64537-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  41 in total

1.  Chronic relapsing experimental allergic encephalomyelitis: morphological sequence of myelin degradation.

Authors:  H Lassmann; H M Wisniewski
Journal:  Brain Res       Date:  1979-06-22       Impact factor: 3.252

2.  Axonal dystrophy as a consequence of long-term demyelination.

Authors:  C S Raine; A H Cross
Journal:  Lab Invest       Date:  1989-05       Impact factor: 5.662

3.  The fine structure of chronically active multiple sclerosis plaques.

Authors:  J W Prineas; F Connell
Journal:  Neurology       Date:  1978-09       Impact factor: 9.910

4.  Increased diameter of demyelinated axons in chronic multiple sclerosis of the spinal cord.

Authors:  M Shintaku; A Hirano; J F Llena
Journal:  Neuropathol Appl Neurobiol       Date:  1988 Nov-Dec       Impact factor: 8.090

5.  Neuronal damage in T1-hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy.

Authors:  M A van Walderveen; F Barkhof; P J Pouwels; R A van Schijndel; C H Polman; J A Castelijns
Journal:  Ann Neurol       Date:  1999-07       Impact factor: 10.422

Review 6.  The pathology of multiple sclerosis and its evolution.

Authors:  H Lassmann
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-10-29       Impact factor: 6.237

7.  Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.

Authors:  N De Stefano; P M Matthews; L Fu; S Narayanan; J Stanley; G S Francis; J P Antel; D L Arnold
Journal:  Brain       Date:  1998-08       Impact factor: 13.501

8.  Axonal regeneration in old multiple sclerosis plaques. Immunohistochemical study with monoclonal antibodies to phosphorylated and non-phosphorylated neurofilament proteins.

Authors:  D Dahl; G Perides; A Bignami
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

9.  Axonal degeneration in demyelinating disorders.

Authors:  R E Madrid; H M Wiśniewski
Journal:  J Neurocytol       Date:  1977-02

10.  Adoptively transferred chronic relapsing experimental autoimmune encephalomyelitis in the mouse. Neuropathologic analysis.

Authors:  C S Raine; F Mokhtarian; D E McFarlin
Journal:  Lab Invest       Date:  1984-11       Impact factor: 5.662

View more
  237 in total

1.  Analysis of normal-appearing white matter in multiple sclerosis: comparison of diffusion tensor MR imaging and magnetization transfer imaging.

Authors:  A C Guo; V L Jewells; J M Provenzale
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

2.  Dendritic and synaptic pathology in experimental autoimmune encephalomyelitis.

Authors:  Bing Zhu; Liqing Luo; G R Wayne Moore; Donald W Paty; Max S Cynader
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

3.  The relevance of animal models in multiple sclerosis research.

Authors:  Aleksandar Denic; Aaron J Johnson; Allan J Bieber; Arthur E Warrington; Moses Rodriguez; Istvan Pirko
Journal:  Pathophysiology       Date:  2011-02

Review 4.  Recent neuropathological findings in MS--implications for diagnosis and therapy.

Authors:  Hans Lassmann
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

5.  Short-term stability of T1 and T2 relaxation measures in multiple sclerosis normal appearing white matter.

Authors:  Alice L W Liang; Irene M Vavasour; Burkhard Mädler; Anthony L Traboulsee; Donna J Lang; David K B Li; Alex L MacKay; Cornelia Laule
Journal:  J Neurol       Date:  2011-11-26       Impact factor: 4.849

6.  Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells.

Authors:  LiPing Liu; Lindsey Darnall; Taofang Hu; Karen Choi; Thomas E Lane; Richard M Ransohoff
Journal:  J Neurosci       Date:  2010-07-07       Impact factor: 6.167

Review 7.  Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.

Authors:  Ranjan Dutta; Bruce D Trapp
Journal:  Prog Neurobiol       Date:  2010-10-12       Impact factor: 11.685

Review 8.  Review: Mitochondria and disease progression in multiple sclerosis.

Authors:  D Mahad; H Lassmann; D Turnbull
Journal:  Neuropathol Appl Neurobiol       Date:  2008-12       Impact factor: 8.090

9.  Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation.

Authors:  Roberta Brambilla; Trikaldarshi Persaud; Xianchen Hu; Shaffiat Karmally; Valery I Shestopalov; Galina Dvoriantchikova; Dmitry Ivanov; Lubov Nathanson; Scott R Barnum; John R Bethea
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

10.  An increase in tolerogenic dendritic cell and natural regulatory T cell numbers during experimental autoimmune encephalomyelitis in Rras-/- mice results in attenuated disease.

Authors:  Avijit Ray; Sreemanti Basu; Nichole M Miller; Andrew M Chan; Bonnie N Dittel
Journal:  J Immunol       Date:  2014-04-25       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.